ArticleFrontiers in oncology2026
Early efficacy and safety of spinal endoscopy assisted anterior cervical discectomy and fusion in the treatment of cervical spondylotic myelopathy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To introduce a new surgical approach for spinal endoscopy assisted anterior cervical discectomy and fusion (Endo-ACDF) in treating cervical spondylotic myelopathy (CSM) and to report the clinical results after a 2-year follow-up. Methods: The clinical data of 123 CSM patients who underwent ACDF from February 2020 to February 2022 were retrospectively analyzed. They were divided into two groups: Open-ACDF and Endo-ACDF, based on different surgical methods. Baseline data, hospitalization duration, operation time, intraoperative blood loss, postoperative drainage, and postoperative Japanese orthopedic association (JOA) score, neck disability index (NDI), visual analogue scale (VAS) scores and imaging results were compared between the two groups. Results: There was no statistically significant difference between the baseline data of the two groups ( Conclusion: Endo-ACDF combines the endoscopic system with ACDF technology for treating CSM, demonstrating clinical efficacy comparable to Open-ACDF. Compared to Open-ACDF, Endo-ACDF offers a clearer surgical field, improved intraoperative hemostasis, and reduced intraoperative blood loss and postoperative drainage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.